METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OSTEOARTHRITIS

Osteoarthritis (OA) is a type of degenerative joint disease that results from breakdown of joint cartilage and underlying bone. Here, the inventors studied the effects of intra-articular anti-GD3 monoclonal antibody injection. The present invention relates to a method for treating osteoarthritis in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of a GD3 inhibitor.

Keywords: musculoskeletal disorders, osteoarthritis
Patent Application number: European Procedure (Patents) (EPA) - 21 Oct. 2022 - 22 306 604.4
Inventors:
BRONDELLO Jean-marc; JORGENSEN Christian; PERS Yves-Marie; CHERFILS Julien

Reference:

BIO16170-T1

Business Developper
contact
Inserm Transfert
Business Developer
Patent filling date: 2016-07-28

You might also be interested in